Johnson & Johnsonreached a deal with the US government to lower drug prices for some Americans, joining a cadre of major pharmaceutical companies to make price concessions in exchange for tariff exemption.
The American drugmaker was one of 17 companies President Donald Trump called on last summer to lower prices, and among the last ones to announce a deal. The two remaining companies are AbbVie Inc. and Regeneron Pharmaceuticals Inc., which previously said they are in talks with the White House.
As part of the deal, J&J will offer its drugs to the Medicaid program at comparable prices ...
